Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Integrated Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00904072
First received: May 17, 2009
Last updated: May 18, 2009
Last verified: May 2009
  Purpose

The purpose of this study is to understand the impact of CDSS by knowing the prescribers actions to the CDSS, also the influence of prescribing error announced by pharmacists.


Condition
Evaluate the Impact of the CDSS

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Integrated a Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 50000
Study Start Date: February 2009
Groups/Cohorts
accepted
The suggestions provided by the CDSS which were accepted by the physicians.
denied
The suggestions provided by the CDSS which were denied by the physicians.

Detailed Description:
  1. To assess the sensitivity of the CDSS which could identify some specific prescribing errors (ex: duplication of drugs, dosage that exceed the maximum dose,prescribes drugs that have drug-drug interactions).
  2. To identify what kind of drugs are most likely to cause duplication use by the physicians, and what kind of drugs are most likely to exceed the maximum dosage, also to know what kind of drugs are most likely to cause drug-drug interaction that physicians encounter during prescribing.
  3. To evaluate the percentage of physician acceptance of the prescribing errors identify by the CDSS.
  4. What's the impact of CDSS on pharmacist announced prescribing error.
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

The prescriptions which induced the alert windows pop out.

Criteria

Inclusion Criteria:

  • The prescriptions which induced the alert windows pop out.

Exclusion Criteria:

  • The prescriptions which not induced the alert windows pop out.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00904072

Contacts
Contact: Fe-Lin Lin Wu, Associate Professor 886-2-23123456 ext 88389 flwu@ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Taipei, Taiwan Recruiting
Taipei, Taiwan
Contact: Fe-Lin Lin Wu    886-2-23123456 ext 88389    flwu@ntu.edu.tw   
Principal Investigator: Fe-Lin Lin Wu         
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Fe-Lin Lin Wu, Associate Professor National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: Fe-Lin Lin Wu/Associate Professor, Grauduate Institute of Clinical Pharmacy, College of medicine, National Taiwan university, Grauduate Institute of Clinical Pharmacy
ClinicalTrials.gov Identifier: NCT00904072     History of Changes
Other Study ID Numbers: 20080306OR
Study First Received: May 17, 2009
Last Updated: May 18, 2009
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
CDSS
prescribing error
prescribing errors influenced by CDSS
CPOE

ClinicalTrials.gov processed this record on November 23, 2014